Literature DB >> 3349232

Clonidine and morphine increase [3H]-noradrenaline overflow in mouse vas deferens.

K M Forsyth1, D Pollock.   

Abstract

1. Field stimulation of mouse isolated vas deferens produced a biphasic contraction that consisted of an initial brief non-adrenergic, non-cholinergic (NANC) twitch, followed by a more prolonged noradrenergic component. 2. Field stimulation of vasa, previously loaded with [3H]-noradrenaline ([3H]-NA), increased the amount of radioactivity in the Krebs bathing solution; 77% of this radioactivity was derived from [3H]-NA. 3. Tetrodotoxin (3 x 10(-6) M) abolished the biphasic motor response to field stimulation and the accompanying increased overflow of [3H]-NA. 4. Morphine (10(-7)-10(-5) M) inhibited the initial NANC component but potentiated the secondary noradrenergic component of the motor response to field stimulation. Morphine also increased the field stimulation-induced overflow of radioactivity. Naloxone (10(-6) M) antagonized the effects of morphine on the motor response and also on the overflow of radioactivity. 5. Clonidine (10(-9)-10(-7) M) inhibited the initial NANC component but potentiated the secondary noradrenergic component of the motor response to field stimulation. Clonidine also increased the field stimulation-induced overflow of radioactivity. 6. The ability of morphine (10(-7) M) and of clonidine (10(-9) M) to potentiate the field stimulation-induced overflow of radioactivity persisted in the presence of a combination of tranylcypromine (10(-5) M), desmethylimipramine (10(-5) M) and 17-beta-oestradiol (10(-5) M). 7. The inhibition of the initial NANC component of the motor response to field stimulation produced by morphine and clonidine may be related to the ability of these drugs to potentiate both the secondary noradrenergic component and the overflow of radioactivity, if the NANC transmitter is involved in regulating NA release.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349232      PMCID: PMC1853765          DOI: 10.1111/j.1476-5381.1988.tb11402.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Proceedings: Is morphine inhibition to the twitch response of the mouse vas deferens mediated via noradrenaline?

Authors:  D A Jenkins; I Marshall; P A Nasmyth
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Clonidine enhances the secretion of sympathetic neurotransmitter from isolated guineq-pig tissues.

Authors:  L Stjärne
Journal:  Acta Physiol Scand       Date:  1975-01

3.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

4.  A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens.

Authors:  G Henderson; J Hughes; H W Kosterlitz
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

5.  Evidence to support the hypothesis that ATP is a co-transmitter in rat vas deferens.

Authors:  A M French; N C Scott
Journal:  Experientia       Date:  1983-03-15

6.  Evidence that ATP acts as a co-transmitter with noradrenaline in sympathetic nerves supplying the guinea-pig vas deferens.

Authors:  L A Meldrum; G Burnstock
Journal:  Eur J Pharmacol       Date:  1983-08-19       Impact factor: 4.432

7.  Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics.

Authors:  J Hughes; H W Kosterlitz; F M Leslie
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

8.  The effects of morphine on the release of noradrenaline from the mouse vas deferens.

Authors:  G Henderson; J Hughes
Journal:  Br J Pharmacol       Date:  1976-08       Impact factor: 8.739

9.  Relative pre- and postjunctional roles of noradrenaline and adenosine 5'-triphosphate as neurotransmitters of the sympathetic nerves of guinea-pig and mouse vas deferens.

Authors:  L Stjärne; P Astrand
Journal:  Neuroscience       Date:  1985-03       Impact factor: 3.590

10.  Contribution by purines to the neurogenic response of the vas deferens of the guinea pig.

Authors:  J S Fedan; G K Hogaboom; J P O'Donnell; J Colby; D P Westfall
Journal:  Eur J Pharmacol       Date:  1981-01-05       Impact factor: 4.432

View more
  3 in total

1.  Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens.

Authors:  L D Todorov; S Mihaylova-Todorova; G L Craviso; R A Bjur; D P Westfall
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

2.  Interactions of calcium antagonists and the calcium channel agonist Bay K 8644 on neurotransmission of the mouse isolated vas deferens.

Authors:  G A Rae; J B Calixto
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

3.  Effect of opioid receptor subtype-selective agonists on purinergic and adrenergic components of neurogenic contractions of mouse vas deferens.

Authors:  B Driessen; R Bültmann; I von Kügelgen; K Starke
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.